All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Marina Biotech Inc., of Boston, closed its issuance of series C convertible preferred stock and common stock purchase warrants for gross proceeds of $6 million.
